On April 9, 2025, the pharma stocks are under scanner on D-Street with Nifty Pharma index dropping ~2% to 20,063.40 at 09:45 AM. The top losers of Nifty Pharma Index were Biocon, Laurus Labs, Gland Pharma, Ipca Labs, Lupin with a fall of 3.57%, 3.18%, 2.94%, 2.91% and 2.62%, respectively.
Gland Pharma share price experienced the sharpest fall, crashing 6% to a low of Rs 1,340.15 on the BSE, followed by Aurobindo Pharmaceuticals and Dr Reddy’s Laboratories, which fell 5% and 4.2% respectively.
During his speech at the Republican NRCC event, Trump announced that significant tariffs on pharmaceuticals would soon be implemented.
“Tariffs on pharmaceuticals will be introduced because we don’t produce our own drugs; they are made in other countries. The same product in the U.S. can sometimes cost up to ten times more. We’re going to impose tariffs on pharma in such a way that companies will rush to the U.S. The advantage we have is our massive market. Very soon, we will announce major tariffs on pharma, and once these companies hear that, they’ll leave China and other countries, as most of their products are sold here. They’ll be setting up their plants here,” Trump said.
Also Read: Nifty Pharma Index Fell 7% Straight in a Single Day
The sharp fall in pharma shares on April 9, 2025, appears to be linked to the announcement by US President Donald Trump regarding the imminent imposition of significant tariffs on pharmaceutical imports.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Apr 9, 2025, 10:08 AM IST
Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
